Abstract
Replication deficient adenovirus vectors are frequently used tools for the delivery of transgenes in vitro and in vivo. In addition, several therapeutic products based on adenovirus are under clinical development. This review outlines adenovirus vector production discussing different vector types, available production cell lines and state of the art of production process development and purification.
Keywords: Adenovirus, adenovirus vector, production, production cell lines, process development, purification, oncolytic Ad vectors, E1Ad, hAd5, E2A, DNA-binding protein, E2B (polymerase and preterminal protein, E1, E2, E3 and E4, pol, pTP, (HC-Ad) vector, human embryonic kidney (HEK) cells, keratinocytes, hepatocytes, urothelial cells, plasmid expressing, human embryonic retinoblasts, RCA, phosphoglycerate kinase (pgk) promoter, PER.C6, helper-dependent E1-positive particles (HDEPs), E1/pIX genes, N52.E6, A549 cells, 293, 911, NCL, GH329, Ac51 Ac139, SL0003, cell concentration at infection (CCI), multiplicity of infection (MOI), Cytodex-1, Cytodex-3 microcarriers, FLPe, HDAd, TOI, time of harvest (TOH), TCA cycle, Metabolic flux analysis, DO, pCO2, polysorbate-80, Pluronic-F68, plaque-forming unit (PFU), tissue culture infectious dose 50 (TCID50), EM, high performance liquid chromatography (HPLC), Adenovirus Reference Material Working Group (ARMWG), GFP-expressing AdV, Canji, Schering, Aventis, Introgen, Merck, AEX (Fractogel DEAE, AEX (Toyopearl SuperQ, immobilized metal affinity chromatography (IMAC)
Current Gene Therapy
Title: Adenovirus Vector Production and Purification
Volume: 10 Issue: 6
Author(s): Ana Carina Silva, Cristina Peixoto, Tanja Lucas, Claudia Kuppers, Pedro E. Cruz, Paula M. Alves and Stefan Kochanek
Affiliation:
Keywords: Adenovirus, adenovirus vector, production, production cell lines, process development, purification, oncolytic Ad vectors, E1Ad, hAd5, E2A, DNA-binding protein, E2B (polymerase and preterminal protein, E1, E2, E3 and E4, pol, pTP, (HC-Ad) vector, human embryonic kidney (HEK) cells, keratinocytes, hepatocytes, urothelial cells, plasmid expressing, human embryonic retinoblasts, RCA, phosphoglycerate kinase (pgk) promoter, PER.C6, helper-dependent E1-positive particles (HDEPs), E1/pIX genes, N52.E6, A549 cells, 293, 911, NCL, GH329, Ac51 Ac139, SL0003, cell concentration at infection (CCI), multiplicity of infection (MOI), Cytodex-1, Cytodex-3 microcarriers, FLPe, HDAd, TOI, time of harvest (TOH), TCA cycle, Metabolic flux analysis, DO, pCO2, polysorbate-80, Pluronic-F68, plaque-forming unit (PFU), tissue culture infectious dose 50 (TCID50), EM, high performance liquid chromatography (HPLC), Adenovirus Reference Material Working Group (ARMWG), GFP-expressing AdV, Canji, Schering, Aventis, Introgen, Merck, AEX (Fractogel DEAE, AEX (Toyopearl SuperQ, immobilized metal affinity chromatography (IMAC)
Abstract: Replication deficient adenovirus vectors are frequently used tools for the delivery of transgenes in vitro and in vivo. In addition, several therapeutic products based on adenovirus are under clinical development. This review outlines adenovirus vector production discussing different vector types, available production cell lines and state of the art of production process development and purification.
Export Options
About this article
Cite this article as:
Carina Silva Ana, Peixoto Cristina, Lucas Tanja, Kuppers Claudia, E. Cruz Pedro, M. Alves Paula and Kochanek Stefan, Adenovirus Vector Production and Purification, Current Gene Therapy 2010; 10 (6) . https://dx.doi.org/10.2174/156652310793797694
DOI https://dx.doi.org/10.2174/156652310793797694 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Poly(ethylene glycol)-polypeptide Copolymer Micelles for Therapeutic Agent Delivery
Current Pharmaceutical Biotechnology Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment
MicroRNA Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Physiological Roles of Neurite Outgrowth Inhibitors in Myelinated Axons of the Central Nervous System – Implications for the Therapeutic Neutralization of Neurite Outgrowth Inhibitors
Current Pharmaceutical Design Unsupervised End-to-End Brain Tumor Magnetic Resonance Image Registration Using RBCNN: Rigid Transformation, B-Spline Transformation and Convolutional Neural Network
Current Medical Imaging P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain
Current Medicinal Chemistry Application of Spray-drying and Electrospraying/Electospinning for Poorly Watersoluble Drugs: A Particle Engineering Approach
Current Pharmaceutical Design Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part II
CNS & Neurological Disorders - Drug Targets Exploiting Microglial Functions for the Treatment of Glioblastoma
Current Cancer Drug Targets Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19
Current Pharmaceutical Design Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Current Pharmaceutical Biotechnology PET Imaging for Gene & Cell Therapy
Current Gene Therapy Molecular Basis for the Neuroprotective Properties of FKBP-Binding Immunophilin Ligands
Current Medicinal Chemistry - Central Nervous System Agents Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)
Current Pharmaceutical Design Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Subject Index to Volume 3
Current Gene Therapy